IP Library Granted Patent US 9,109,052
Granted Patent B2
US 9,109,052 · App. 13/512,484 · Granted Aug 18, 2015

Method of preparation of an oxidized derivative of hyaluronic acid and a method of modification thereof

Inventors: Radovan Buffa (Humenne, SK); Sofiane Kettou (Uherske Hradiste, CZ); Lucie Pospisilova (Svitavy, CZ); Gloria Huerta-Angeles (Ceska Trebova, CZ); Drahomira Chladkova (Letohrad, CZ); Vladimir Velebny (Zamberk, CZ)
Assignee: Contipro Pharma A.S.
C08B37/0072
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,109,052
App. No.
13/512,484
Granted
Aug 18, 2015
Kind
B2
Abstract

The invention relates to a new method of preparation of a hyaluronan derivative with an aldehydic group in the position (6) of the polysaccharide glucosamine part. The hyaluronic acid oxidation can be performed by means of TEMPO/NaCIO or TEMPO/TCC systems in a protic environment with or without the presence of anorganic salts. Thus prepared aldehyde can be used for binding amines, diamines, amino acids, peptides and other compounds containing an amino group, e.g. by means of the reductive amination with NaBH 3 CN in water or in a water-organic solvent system. When a diamine or compounds containing three or more amino groups are used, cross-linked hyaluronan derivatives can be prepared. Cross-linked derivatives can be also prepared by a reaction of the aldehyde with a hyaluronan substituted by an amino-alkyl group HA-alkyl-NH 2 .

Claims (21)

1. A method of preparation of an oxidized derivative of hyaluronic acid comprising:

reacting hyaluronic acid with 4-R-TEMPO and a co-oxidant in a protic solvent, where R is a linear or branched alkyl chain, optionally containing aromatic or heteroaromatic groups, wherein the oxidized derivative of hyaluronic acid is selectively oxidized to an aldehyde at position 6 of the glucosamine portion of the derivative and 4-R-TEMPO is present in an amount within the range from 0.005 to 0.5 molar equivalent with respect to the hyaluronic acid.

2. The method of preparation according to claim 1 , wherein the co-oxidant includes sodium hypochlorite or TCC (trichlorocyanuric acid).

3. The method of preparation according to claim 1 , wherein the hyaluronic acid is in the form of a free acid or a salt.

4. The method of preparation according to claim 1 , wherein the hyaluronic acid molecular weight is within the range from 1·10 4 to 5·10 6 g·mol −1 .

5. The method of preparation according to claim 1 , wherein the protic solvent includes water and aqueous solutions of salts of a general formula MX, where M is an alkali metal and X is selected from the group including HCO 3 − , CO 3 2− , PO 4 3− , HPO 4 2− , H 2 PO 4 − and halogens.

6. The method of preparation according to claim 5 , wherein the concentration of the aqueous salt solutions is 0 to 15% by weight.

7. The method of preparation according to claim 1 , wherein reaction of the hyaluronic acid, 4-R-TEMPO and the co-oxidant is performed at the temperature within the range from −10 to 20° C. for 5 minutes to 24 hours.

8. The method of preparation according to claim 1 , wherein the co-oxidant is present in an amount within the range from 0.05 to 1 molar equivalent with respect to the hyaluronic acid.

9. The method of preparation according to claim 1 , wherein the solvent is water or a mixture of water and a polar aprotic solvent with the content of water of at least 30% (v/v).

10. A method of modification of the hyaluronic acid derivative prepared by the method of claim 1 comprising:

reacting the oxidized hyaluronic acid derivative with either a compound of a general formula H 2 N—R, where the general formula H 2 N—R defines an amino acid, peptide, or polysaccharide containing a free amino group or where R is a linear or branched C 1 -C 30 alkyl chain, optionally containing aromatic or heteroaromatic groups, thereby defining an amine, or with a hyaluronan, substituted by an —R—NH 2 group, where R is a linear or branched C 1 -C 30 alkyl chain, optionally containing aromatic or heteroaromatic groups, to form an imino form of HA of a general formula I

11. The method of modification according to claim 10 , wherein the oxidized hyaluronic acid derivative reacts with the amino acid.

12. The method of modification according to claim 10 , wherein the oxidized hyaluronic acid derivative reacts with the peptide.

13. The method of modification according to claim 10 , wherein the oxidized hyaluronic acid derivative reacts with the polysaccharide containing a free amino group.

14. The method of modification according to claim 10 , wherein the oxidized hyaluronic acid derivative reacts with the amine, amino acid, peptide, or polysaccharide and the amount of the amine, amino acid, peptide or polysaccharide is within the range from 0.05 to 10 molar equivalents with respect to the hyaluronic acid derivative.

15. The method of modification according to claim 10 , wherein the oxidized hyaluronic acid derivative reacts with the amine, amino acid, peptide, or polysaccharide and the reaction of the oxidized hyaluronic acid derivative with the amine, amino acid, peptide or polysaccharide is performed in water or in a system of water-organic solvent at the temperature within the range from 0 to 80° C. for 1 minute to 24 hours.

16. The method of modification according to claim 15 , wherein the oxidized hyaluronic acid derivative reacts with the amine, amino acid, peptide, or polysaccharide and the reaction of the oxidized hyaluronic acid derivative with the amine, amino acid, peptide or polysaccharide is performed in the presence of NaBH 3 CN as a reduction agent, which is added to the reaction mixture in time 0 to 100 hours after the addition of the amine, amino acid, peptide or polysaccharide, to form an amino form of HA of a general formula II

17. The method of modification according to claim 16 , wherein the amount of NaBH 3 CN as a reduction agent is within the range from 0 to 20 molar equivalents with respect to the molar amount of the aldehyde.

18. The method of modification according to claim 15 , wherein the organic solvent is selected from the group comprising water-miscible alcohols, and water-miscible polar aprotic solvents.

19. The method of modification according to claim 15 , wherein the amount of water is at least 50% (v/v) with respect to the volume of the whole solution.

Assignments (2)
CHANGE OF NAME Recorded May 25, 2017
From: CONTIPRO PHARMA A.S.
To: CONTIPRO A.S.
Reel/Frame 042746/0683 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2012
From: BUFFA, RADOVAN; KETTOU, SOFIANE; POSPISILOVA, LUCIE; HUERTA-ANGELES, GLORIA; CHLADKOVA, DRAHOMIRA; VELEBNY, VLADIMIR
To: CONTIPRO PHARMA A. S.
Reel/Frame 028724/0001 →
Priority Claims (1)
CZ PV2009-835 · Dec 11, 2009 · national
Continuity (1)
Related Publication 20120264913A1 · Oct 18, 2012